ADTX vs JNJ · rev $3.2K vs P/E 17, rev $49.37B
Aditxt Inc. (ADTX) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
Aditxt Inc. (ADTX) is a biotechnology company listed on NASDAQ.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported ADTX revenue for 2025-12-31 was $3.2K. Net income was -$43.1M. Revenue was down 97.6% from 2024-12-31 to 2025-12-31. ADTX currently screens at market cap $3.6K.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
ADTX currently screens at market cap $3.6K. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the ADTX and JNJ stock pages for the full models.
Not investment advice.